title: Effect of nucleosides and a nucleotide mixture on proliferation of human gastric cancer cells (KATO III).
abstract: The effect of the nucleotides and a nucleotide mixture (OG-VI), consisting of inosine, guanosine 5'-monophosphate (5'-GMP), cytidine, uridine, thymidine (TdR) (4:4:4:3:1 in molar ratio), and TdR co-administration on proliferation of KATO III human gastric cancer cells in culture was evaluated. Consumption of purine and pyrimidine by cancer cells and changes in cell number with OG-VI or TdR were compared with the control culture medium (Williams E) after 72 hour-culture. Addition of OG-VI or TdR did not enhance the cellular proliferation, but inhibited growth when given in higher concentrations (0.3-3 mM inosine, 0.3-3 mM 5'-GMP, 0.22-2.2 mM uridine, 74-740 microM TdR). Consumption rate of TdR in the medium was less in the TdR group, 33.7%, than in the OG-VI group, 72.2% (p < 0.05). This suggests that TdR metabolism is modulated by other nucleosides and nucleotide included in OG-VI. Under the coadministration of 5-fluorouracil (FUra), addition of OG-VI or TdR suppressed cellular proliferation (p < 0.05). The inhibition rate of cellular proliferation in the OG-VI group was slightly higher than the TdR group, but there was no statistically significant difference between the two groups. The combination of FUra with OG-VI or TdR enhances the antitumor effect of FUra. It is concluded that the OG-VI does not enhance the tumor cell proliferation and it is a potential biochemical modulator of FUra metabolism in human cancer cells.
authors: Sun Yat-seen University of Medical Sciences, Guangzhou, P.R. China.
authors: J
authors: J
authors: Wang
authors: M
authors: M
authors: Usami
authors: I
authors: I
authors: Yasuda
authors: H
authors: H
authors: Kasahara
authors: G
authors: G
authors: Kotani
authors: Y
authors: Y
authors: Cao
authors: J
authors: J
authors: Zheng
authors: A
authors: A
authors: Iso
authors: T
authors: T
authors: Kanamaru
authors: H
authors: H
authors: Ohyanagi
mesh_terms: D002455:Cell Division / Q000187:drug effects; D004338:Drug Combinations; D006801:Humans; D009705:Nucleosides / Q000494:pharmacology*; D009711:Nucleotides / Q000494:pharmacology*; D013274:Stomach Neoplasms / Q000473:pathology*; D014407:Tumor Cells, Cultured
chemical_list: D004338:Drug Combinations; D009705:Nucleosides; D009711:Nucleotides